SAN MARCOS, Texas, Oct. 30 /PRNewswire/ -- The developer of a product, known as ALKA-V6, a proprietary modified silicon-based compound that is the subject of ongoing research as a potential cancer fighting weapon, has been named to the Committee of Advisors for the College of Applied Arts at Texas State University.
Ignacius Cisneros, of Odessa, Texas, has agreed to serve on the advisory board of Alumni and business leaders.
In inviting Cisneros to participate, Dr. Jaime Chahin, Dean of the College of Applied Arts stated, "Your experience, expertise, and professional networks will assist the College in achieving our educational goals...Your professional input and guidance are of utmost importance regarding our College's vision and academic strategies."
The University has become well acquainted with Mr. Cisneros because of the sponsored research projects between his company, CISNE Enterprises and TSU.
Recently, Texas State University conducted a year long battery of successful in vitro tests to determine cancer chemotherapeutic and anti-retroviral effects of the ALKA-V6 compound on cancer cells and the HIV virus.
University researchers concluded, "The unique electrochemical and structural composition of ALKA-V6 indicates that it may provide an alternative basis for control of cancer cell growth and virus survival. However, this implication is based solely on in-vitro results and end-point in-vivo evaluations are imperative." The University and CISNE are discussing additional research activities.
University faculty researchers, Drs. Reed Richardson and Diraj Vattem plan to present their findings and publish results in scientific journals in 2010.
Orizon Research Institute of Odessa, Texas is the international distributor of ALKA V-6. Orizon remains committed to providing the ALKA-V6 compound to the general public as an affordably priced nutritional supplement that can be pu
|SOURCE Orizon Research Institute|
Copyright©2009 PR Newswire.
All rights reserved